glp-1 gip therapies weight management effectiveness The Glucagon Paradox In Next-Generation Incretin Therapy: GLP-1, GIP, And Glucagon Receptor Co-Agonism GlobalRPH Nutritional priorities to support GLP-1

Description

[DOI] [PMC free article] [PubMed] [Google Scholar] 252.Zhou H, Zhang T, Harmon JS, Bryan J, Robertson RP

Several large-scale clinical trials and post-marketing surveillance studies have reported higher rates of cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) among patients treated with GLP-1 agonists compared to placebo or other glucose-lowering medications

GLP-1 weight loss injections are considered safe for most individuals when used under the supervision of a healthcare provider

Key Takeaway: Ozempic was never intended to be taken at a 3mg dose

Patients with T2DM treated with denosumab exhibit lower glycated hemoglobin levels compared with those treated with bisphosphonates or calcium and vitamin D supplementation, highlighting the role of the RANK-RANKL system and implicating DPP-4 as a potential mediator between bone remodeling and energy metabolism [3]